Error loading player: No playable sources found
SatCU1
Non-Small Cell Lung Cancer: Biomarker Testing Recommendations
Date
March 20, 2021
Learning Objectives
- Review the recommended actionable oncogenic biomarkers for eligible patients with metastatic non-small cell lung cancer (NSCLC).
- Identify the recommended immune biomarkers for eligible patients with metastatic NSCLC.
- Describe the need for biomarker testing for eligible patients with metastatic NSCLC.
Speaker
Dara L. Aisner, MD, PhD
University of Colorado Cancer Center
